Proceedings of the National Academy of Sciences, Volume 122, Issue 22, June 2025. SignificanceNav1.8 sodium channels are highly expressed in primary pain-sensing neurons. Suzetrigine is a potent and highly selective Nav1.8 inhibitor that has recently been approved by the Food and Drug Administration for treating acute pain. We find …